Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,818,740
+$22,471,084 QoQ
Shares Held
4,481,874
+90.9% QoQ
Ownership
1.75%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. BCRX ranks #14 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,818,740 | 4,481,874 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22,347,656 | 2,347,443 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,059,722 | 3,212,785 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $20,582,607 | 2,711,806 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $31,574,294 | 3,523,917 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,489,504 | 1,931,934 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $9,710,048 | 1,291,230 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $17,636,019 | 2,320,529 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,636,999 | 2,530,259 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,780,853 | 1,925,365 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,630,774 | 1,774,754 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $10,922,393 | 1,542,711 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,410,673 | 1,478,789 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $9,396,726 | 1,126,706 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $12,991,846 | 1,131,694 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $18,511,352 | 1,469,155 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $14,565,612 | 1,376,712 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $20,709,141 | 1,273,625 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,269,190 | 813,660 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $11,031,776 | 767,695 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $12,808,660 | 810,162 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $22,074,899 | 2,170,590 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,262,080 | 303,635 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,056,593 | 1,469,940 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,589,438 | 2,224,672 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,929,080 | 1,464,540 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||